If, instead, the effect of SARS-CoV-2 is postulated to be indirect, via inflammation, this could act as a reactivator of HSV1 in brain which, in APOE-ε4 carriers would lead to AD, i.e., would not be attributable to SARS-CoV. This evidence concerns the gene APOE and Alzheimer disease.